Cardiovascular & Metabolic Diseases
Breath biomarkers could lead to non-invasive detection and monitoring for liver disease, diabetes, kidney disease, heart failure and other cardiovascular and metabolic diseases
Find out more
Webinar: Identifying Translational Biomarkers using Breath Biopsy in vitro Headspace Analysis
A webinar introducing in vitro methods to investigate volatile metabolites as potential translational biomarkers
View Presentation
Article: Insights into potential VOC biomarkers of diabetes
Non-invasive breath testing offers an attractive alternative to currently available diabetes tests for diagnosis and ongoing monitoring
Read Review
Article: Examining candidate breath biomarkers for kidney disease
A non-invasive breath test could allow for cheaper screening and earlier intervention, when damage is less severe
View Publication
Case Study: Could acetone be a biomarker of heart failure?
Current biomarkers of heart function are very invasive but evidence suggests breath acetone could be useful for both diagnosis and prognosis
Read Case study
Paper: Breath Biopsy to identify exhaled VOCs as biomarkers for liver cirrhosis
A study to discover VOCs for early detection of progressive liver disease
VIEW PAPER
We’ve worked on cardiovascular and metabolic disease with these groups:
 |
 |
 |
Other recommended reading:
- POSTER: Pre-clinical in vitro VOC analysis to identify biomarker candidates for chronic liver diseases detection – A Breath Biopsy study.
- PAPER: Targeted breath analysis: exogenous volatile organic compounds (EVOC) as metabolic pathway-specific probes
- PAPER: VOCs from Exhaled Breath for the Diagnosis of Hepatocellular Carcinoma
- PAPER: Optimization of a breath analysis methodology to potentially diagnose transplanted kidney rejection
- PAPER: A deep learning approach for detecting liver cirrhosis from volatolomic analysis of exhaled breath
- PAPER: Visualization of exhaled breath metabolites reveals distinct diagnostic signatures for acute cardiorespiratory breathlessness
- REVIEW: Could breath acetone be a potentially useful biomarker for heart failure?
- POSTER: Comparing cirrhosis and liver cancers – A Breath Biopsy study with Cleveland Clinic proposing ketones and terpenes as possible biomarkers of chronic liver diseases
